Cost-effectiveness rankings
| Strategy | Cost ($) | Incremental cost ($) | Effect (QALY) | Incremental effect (QALY) | ICER ($/QALY) | Net monetary benefit |
| Current prevention | 22 751.27 | 5.90 | 566,766.25 | |||
| Tibial neurolysis | 35 523.55 | 12 772.28 | 6.30 | 0.41 | 31 330.78 | 594,759.88 |
Costs in US$. Net monetary benefit uses a willingness-to-pay of $100 000.
ICER, incremental cost-effectiveness ratio; QALY, quality-adjusted life years .